TNF-blockade in patients with advanced hormone refractory prostate cancer

被引：5
作者：
Diaz, Luis A., Jr. [1 ,2 ]
Messersmith, Wells [3 ]
Sokoll, Lori [2 ,4 ]
Sinibaldi, Vicki [2 ]
Moore, Sandy [2 ]
Carducci, Michael [2 ]
Eisenberger, Mario [2 ]
机构：
[1] Ludwig Ctr Canc Genet & Therapeut Johns Hopkins, Baltimore, MD 21231 USA
[2] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA
[3] Univ Colorado, Div Med Oncol, Ctr Canc, Aurora, CO 80045 USA
[4] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA
来源：
INVESTIGATIONAL NEW DRUGS | 2011年 / 29卷 / 01期
关键词：
Prostate cancer; Hormone refractory; TNF-alpha; Infliximab; IL-6; INTERLEUKIN-6; PATHWAY; GROWTH;
D O I：
10.1007/s10637-009-9346-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：192 / 194
页数：3
相关论文
共 50 条
  • [1] TNF-blockade in patients with advanced hormone refractory prostate cancer
    Luis A. Diaz
    Wells Messersmith
    Lori Sokoll
    Vicki Sinibaldi
    Sandy Moore
    Michael Carducci
    Mario Eisenberger
    Investigational New Drugs, 2011, 29 : 192 - 194
  • [2] Management of patients with hormone refractory prostate cancer
    Muthuramalingam, SR
    Patel, K
    Protheroe, A
    CLINICAL ONCOLOGY, 2004, 16 (08) : 505 - 516
  • [3] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [4] Polyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients
    Cipolla, Bernard G.
    Havouis, Rene
    Moulinoux, Jacques-Philippe
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (05) : 363 - 368
  • [5] ADVANCED PROSTATE CANCER: HORMONE- REFRACTORY DISEASE TREATMENT
    Vicario, Giovanni
    EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (01): : 19 - 24
  • [6] New hope for patients with metastatic hormone-refractory prostate cancer
    de Wit, Ronald
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (15) : 817 - 823
  • [7] Chemotherapy in hormone-refractory prostate cancer
    de Wit, Ronald
    BJU INTERNATIONAL, 2008, 101 : 11 - 15
  • [8] Hormone refractory prostate cancer: Management and advances
    Sonpavde, G
    Hutson, TE
    Berry, WR
    CANCER TREATMENT REVIEWS, 2006, 32 (02) : 90 - 100
  • [9] Hormone refractory advanced prostate cancer treated with estramustine and paclitaxel combination
    Athanasiadis, A
    Tsavdaridis, D
    Rigatos, SK
    Athanasiadis, I
    Pergantas, N
    Stathopoulos, GP
    ANTICANCER RESEARCH, 2003, 23 (3C) : 3085 - 3088
  • [10] CI-980 in advanced melanoma and hormone refractory prostate cancer
    Ryan, CW
    Shulman, KL
    Richards, JM
    Kugler, JW
    Sosman, JA
    Ansari, RH
    Vokes, EE
    Vogelzang, NJ
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (02) : 187 - 191
12345